Combination Treatment with Human Adipose Tissue Stem Cell-derived Exosomes and Fractional CO2 Laser for Acne Scars: A 12-week Prospective, Double-blind, Randomized, Split-face Study

Hyuck Hoon Kwon, Steven Hoseong Yang, Joon Lee, Byung Cheol Park, Kui Young Park, Jae Yoon Jung, Youin Bae, Gyeong-Hun Park, Hyuck Hoon Kwon, Steven Hoseong Yang, Joon Lee, Byung Cheol Park, Kui Young Park, Jae Yoon Jung, Youin Bae, Gyeong-Hun Park

Abstract

A variety of applications of human adipose tissue stem cell-derived exosomes have been suggested as novel cell-free therapeutic strategies in the regenerative and aesthetic medical fields. This study evaluated the clinical efficacy and safety of adipose tissue stem cell-derived exosomes as an adjuvant therapy after application of fractional CO2 laser for acne scars. A 12-week prospective, double-blind, randomized, split-face trial was performed. A total of 25 patients received 3 consecutive treatment sessions of fractional CO2 laser to the whole face, with a follow-up evaluation. Post-laser treatment regimens were applied; for each patient, one side of the face was treated with adipose tissue stem cell-derived exosomes gel and the other side was treated with control gel. Adipose tissue stem cell-derived exosomes-treated sides had achieved a significantly greater improvement than the control sides at the final follow-up visit (percentage reduction in échelle d'évaluation clinique des cicatrices d'acné scores: 32.5 vs 19.9%, p < 0.01). Treatment-related erythema was milder, and post-treatment downtime was shorter on the applications of human adipose tissue stem cell-derived exosomes-treated side. In conclusion, the combined use of this novel material with resurfacing devices would provide synergistic effects on both the efficacy and safety of atrophic acne scar treatments.

Keywords: acne scar; fractional laser; adipose tissue stem cell-derived exosomes.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
Characterization of adipose tissue stem cell-derived exosomes (ASCE). (A) Representative plot of particle concentration and size distribution of ASCE, as measured by nanoparticle tracking analysis (NTA). (B) Cryo-transmission electron microscopy image of ASCE. Scale bar: 200 nm. (C) Signal intensities of exosome surface markers. ASCE were analysed using flow cytometry after staining with anti-CD9, -CD63, and -CD81 antibodies. (D) Levels of exosome exclusionary markers, calnexin and cytochrome C, in ASCE compared with cell lysate. Data are presented as the mean ± standard deviation (SD) of 3 independent experiments.
Fig. 2
Fig. 2
Evaluation of scar improvement based on échelle d’évaluation clinique des cicatrices d’acné (ECCA) scores. (A) Mean percentage changes in total ECCA scores and mean changes in ECCA scores for (B) V-shaped (icepick), (C) U-shaped (boxcar), and (D) M-shaped (rolling) atrophic scars on the adipose tissue stem cell-derived exosomes (ASCE) and control sides. *p < 0.05 compared with baseline; †p < 0.05 between the 2 sides. Error bars indicate standard errors. PT: post-treatment.
Fig. 3
Fig. 3
Clinical photographs of the adipose tissue stem cell-derived exosomes (ASCE) and control sides at baseline and 6 weeks after 3 treatment sessions in a 30-year-old male.
Fig. 4
Fig. 4
Three-dimensional image analyses for atrophic scar, enlarged skin pore, and skin surface roughness using Antera 3D®CS. (A–D) Clinical photographs and analysed images of the adipose tissue stem cell-derived exosomes (ASCE) and control sides at baseline and at the final follow-up visit. (B) The depths of atrophic scars are shown as colours (white<yellow<green<blue<purple). (C) The depths of enlarged skin pores are shown as colours (white<yellow<orange<green<blue). (D) The vertical deviations of the skin surface are shown as colours: [downward] purple<blue<green<white <yellow<red [upward]. Mean percent changes in (E) atrophic scar volume, (F) mean pore volume, and (G) skin surface roughness on the ASCE and control sides. *p < 0.05 compared with baseline. Error bars indicate standard errors. PT: post-treatment.
Fig. 5
Fig. 5
Evaluation of: (A) pain, (B) erythema, (C) oedema, and (D) dryness on both adipose tissue stem cell-derived exosomes (ASCE) and control sides for post-treatment 7 days.
Fig. 6
Fig. 6
Clinical photographs of the adipose tissue stem cell-derived exosomes (ASCE) and control sides for post-treatment 4 days in a 31-year-old male.

References

    1. Wat H, Wu DC, Chan HH. Fractional resurfacing in the Asian patient: current state of the art. Lasers Surg Med 2017; 49: 45–59.
    1. Jordan R, Cummins C, Burls A. Laser resurfacing of the skin for the improvement of facial acne scarring: a systematic review of the evidence. Br J Dermatol 2000; 142: 413–423.
    1. Bradley JA, Bolton EM, Pedersen RA. Stem cell medicine encounters the immune system. Nat Rev Immunol 2002; 2: 859–871.
    1. Kwon HH, Park HY, Choi SC, Bae Y, Kang C, Jung JY, et al. . Combined fractional treatment of acne scars involving non-ablative 1,550-nm erbium-glass laser and micro-needling radiofrequency: a 16-week prospective, randomized split-face study. Acta Derm Venereol 2017; 97: 947–951.
    1. Zhou BR, Zhang T, Bin Jameel AA, Xu Y, Xu Y, Guo SL, et al. . The efficacy of conditioned media of adipose-derived stem cells combined with ablative carbon dioxide fractional resurfacing for atrophic acne scars and skin rejuvenation. J Cosmet Laser Ther 2016; 18: 138–148.
    1. Shin TH, Kim HS, Choi SW, Kang KS. Mesenchymal stem cell therapy for inflammatory skin diseases: clinical potential and mode of action. Int J Mol Sci 2017; 18.
    1. Lou G, Chen Z, Zheng M, Liu Y. Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases. Exp Mol Med 2017; 49: e346.
    1. Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002; 2: 569–579.
    1. Colombo M, Raposo G, Thery C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 2014; 30: 255–289.
    1. Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science 2020; 367: eaau6977.
    1. Golan K, Kumari A, Kollet O, Khatib-Massalha E, Subramaniam MD, Ferreira ZS, et al. . Daily onset of light and darkness differentially controls hematopoietic stem cell differentiation and maintenance. Cell Stem Cell 2018; 23: 572–585e577.
    1. Pelizzo G, Avanzini MA, Icaro Cornaglia A, De Silvestri A, Mantelli M, Travaglino P, et al. . Extracellular vesicles derived from mesenchymal cells: perspective treatment for cutaneous wound healing in pediatrics. Regen Med 2018; 13: 385–394.
    1. Ferreira ADF, Cunha PDS, Carregal VM, da Silva PC, de Miranda MC, Kunrath-Lima M, et al. . Extracellular vesicles from adipose-derived mesenchymal stem/stromal cells accelerate migration and activate AKT pathway in human keratinocytes and fibroblasts independently of miR-205 activity. Stem Cells Int 2017; 2017: 9841035.
    1. Phinney DG, Pittenger MF. Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells 2017; 35: 851–858.
    1. Lai RC, Yeo RW, Lim SK. Mesenchymal stem cell exosomes. Semin Cell Dev Biol 2015; 40: 82–88.
    1. Park JE, Tan HS, Datta A, Lai RC, Zhang H, Meng W, et al. . Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol Cell Proteomics 2010; 9: 1085–1099.
    1. Dreno B, Khammari A, Orain N, Noray C, Merial-Kieny C, Mery S, et al. . ECCA grading scale: an original validated acne scar grading scale for clinical practice in dermatology. Dermatology 2007; 214: 46–51.
    1. Cho BS, Kim JO, Ha DH, Yi YW. Exosomes derived from human adipose tissue-derived mesenchymal stem cells alleviate atopic dermatitis. Stem Cell Res Ther 2018; 9: 187.
    1. Kravvas G, Al-Niaimi F. A systematic review of treatments for acne scarring. Part 1: Non-energy-based techniques. Scars Burn Heal 2017; 3: 2059513117695312.
    1. Min S, Park SY, Moon J, Kwon HH, Yoon JY, Suh DH. Comparison between Er:YAG laser and bipolar radiofrequency combined with infrared diode laser for the treatment of acne scars: differential expression of fibrogenetic biomolecules may be associated with differences in efficacy between ablative and non-ablative laser treatment. Lasers Surg Med 2017; 49: 341–347.
    1. Boen M, Jacob C. A review and update of treatment options using the acne scar classification system. Dermatol Surg 2019; 45: 411–422.
    1. Moon J, Yoon JY, Yang JH, Kwon HH, Min S, Suh DH. Atrophic acne scar: a process from altered metabolism of elastic fibres and collagen fibres based on transforming growth factor-beta1 signalling. Br J Dermatol 2019; 181: 1226–1237.
    1. Holland DB, Jeremy AH, Roberts SG, Seukeran DC, Layton AM, Cunliffe WJ. Inflammation in acne scarring: a comparison of the responses in lesions from patients prone and not prone to scar. Br J Dermatol 2004; 150: 72–81.
    1. Alajlan AM, Alsuwaidan SN. Acne scars in ethnic skin treated with both non-ablative fractional 1,550 nm and ablative fractional CO2 lasers: comparative retrospective analysis with recommended guidelines. Lasers Surg Med 2011; 43: 787–791.
    1. Sundaram H, Cegielska A, Wojciechowska A, Delobel P. Prospective, randomized, investigator-blinded, split-face evaluation of a topical crosslinked hyaluronic acid serum for post-procedural improvement of skin quality and biomechanical attributes. J Drugs Dermatol 2018; 17: 442–450.
    1. Park GH, Rhee do Y, Moon HR, Won CH, Lee MW, Choi JH, et al. . Effect of an epidermal growth factor-containing cream on postinflammatory hyperpigmentation after Q-switched 532-nm neodymium-doped yttrium aluminum garnet laser treatment. Dermatol Surg 2015; 41: 131–135.
    1. Uaboonkul T, Nakakes A, Ayuthaya PK. A randomized control study of the prevention of hyperpigmentation post Q-switched Nd:YAG laser treatment of Hori nevus using topical fucidic acid plus betamethasone valerate cream versus fucidic acid cream. J Cosmet Laser Ther 2012; 14: 145–149.
    1. Farkas JP, Richardson JA, Burrus CF, Hoopman JE, Brown SA, Kenkel JM. In vivo histopathologic comparison of the acute injury following treatment with five fractional ablative laser devices. Aesthet Surg J 2010; 30: 457–464.
    1. Kwon HH, Choi SC, Lee WY, Jung JY, Park GH. Clinical and histological evaluations of enlarged facial skin pores after low energy level treatments with fractional carbon dioxide laser in Korean patients. Dermatol Surg 2018; 44: 405–412.
    1. Choi JH, Shin EJ, Jeong KH, Shin MK. Comparative analysis of the effects of CO2 fractional laser and sonophoresis on human skin penetration with 5-aminolevulinic acid. Lasers Med Sci 2017; 32: 1895–1900.
    1. Ha DH, Kim HK, Lee J, Kwon HH, Park GH, Yang SH, et al. . Mesenchymal stem/stromal cell-derived exosomes for immunomodulatory therapeutics and skin regeneration. Cells 2020; 9: 1157.
    1. Heo JS, Choi Y, Kim HO. Adipose-derived mesenchymal stem cells promote M2 macrophage phenotype through exosomes. Stem Cells Int 2019; 2019: 7921760.
    1. Li X, Xie X, Lian W, Shi R, Han S, Zhang H, et al. . Exosomes from adipose-derived stem cells overexpressing Nrf2 accelerate cutaneous wound healing by promoting vascularization in a diabetic foot ulcer rat model. Exp Mol Med 2018; 50: 29.
    1. McBride JD, Rodriguez-Menocal L, Badiavas EV. Extracellular vesicles as biomarkers and therapeutics in dermatology: a focus on exosomes. J Invest Dermatol 2017; 137: 1622–1629.
    1. Shin KO, Ha DH, Kim JO, Crumrine DA, Meyer JM, Wakefield JS, et al. . Exosomes from human adipose tissue-derived mesenchymal stem cells promote epidermal barrier repair by inducing de novo synthesis of ceramides in atopic dermatitis. Cells 2020; 9: 680.
    1. Hu L, Wang J, Zhou X, Xiong Z, Zhao J, Yu R, et al. . Exosomes derived from human adipose mensenchymal stem cells accelerates cutaneous wound healing via optimizing the characteristics of fibroblasts. Sci Rep 2016; 6: 32993.
    1. Kim WS, Park BS, Sung JH, Yang JM, Park SB, Kwak SJ, et al. . Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci 2007; 48: 15–24.
    1. Wang L, Hu L, Zhou X, Xiong Z, Zhang C, Shehada HMA, et al. . Exosomes secreted by human adipose mesenchymal stem cells promote scarless cutaneous repair by regulating extracellular matrix remodelling. Sci Rep 2017; 7: 13321.
    1. Buch AS, Schjerling P, Kjaer M, Jorgensen LN, Krarup PM, Agren MS. Impaired collagen synthesis in the rectum may be a molecular target in anastomotic leakage prophylaxis. Wound Repair Regen 2017; 25: 532–535.
    1. Kjaer M, Frederiksen AKS, Nissen NI, Willumsen N, van Hall G, Jorgensen LN, et al. . Multinutrient supplementation increases collagen synthesis during early wound repair in a randomized controlled trial in patients with inguinal hernia. J Nutr 2020; 150: 792–799.
    1. Lee JH, Ha DH, Go HK, Youn J, Kim HK, Jin RC, et al. . Reproducible large-scale isolation of exosomes from adipose tissue-derived mesenchymal stem/stromal cells and their application in acute kidney injury. Int J Mol Sci 2020; 21: 4774.
    1. Center for Biologics Evaluation and Research, Food and Drug Administration, U.S. Department of Health and Human Services . Guidance for industry: guidance for human somatic cell therapy and gene therapy. 1998. Available from: .
    1. Center for Biologics Evaluation and Research, Food and Drug Administration, U.S. Department of Health and Human Services . Guidance for FDA reviewers and sponsors: content and review of chemistry, manufacturing, and control (CMC) information for human somatic cell therapy investigational new drug applications (INDs). 2008. Available from: .
    1. Trivedi A, Miyazawa B, Gibb S, Valanoski K, Vivona L, Lin M, et al. . Bone marrow donor selection and characterization of MSCs is critical for pre-clinical and clinical cell dose production. J Transl Med 2019; 17: 128.
    1. Yi YW, Lee JH, Kim SY, Pack CG, Ha DH, Park SR, et al. . Advances in analysis of biodistribution of exosomes by molecular imaging. Int J Mol Sci 2020; 21.
    1. Thery C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. . Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 2018; 7: 1535750.
    1. Zhang B, Yeo RWY, Lai RC, Sim EWK, Chin KC, Lim SK. Mesenchymal stromal cell exosome-enhanced regulatory T-cell production through an antigen-presenting cell-mediated pathway. Cytotherapy 2018; 20: 687–696.
    1. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. . Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–147.
    1. Yeo RWY, Lai RC, Tan KH, Lim SK. Exosome: a novel and safer therapeutic refinement of mesenchymal stem cell. J Circulating Biomarkers 2013; 1: 1–11.
    1. Kordelas L, Rebmann V, Ludwig AK, Radtke S, Ruesing J, Doeppner TR, et al. . MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia 2014; 28: 970–973.
    1. Mendt M, Kamerkar S, Sugimoto H, McAndrews KM, Wu CC, Gagea M, et al. . Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight 2018; 3: e99263.
    1. O’Loughlin AJ, Woffindale CA, Wood MJ. Exosomes and the emerging field of exosome-based gene therapy. Curr Gene Ther 2012; 12: 262–274.
    1. Qin J, Xu Q. Functions and application of exosomes. Acta Pol Pharm 2014; 71: 537–543.
    1. Sun L, Xu R, Sun X, Duan Y, Han Y, Zhao Y, et al. . Safety evaluation of exosomes derived from human umbilical cord mesenchymal stromal cell. Cytotherapy 2016; 18: 413–422.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe